Security
Evaxion A/S American Depositary Share · EVAX
EVAXNASDAQotherCurrentCIK 1828253Updated Nov 10, 2026
Name history
Evaxion Biotech A/S · through May 5, 2025
EVAX price & chart
Loading TradingView…
NASDAQ:EVAX on TradingView ↗About the company
Evaxion A/S is a pioneering clinical-stage TechBio company based upon the Artificial Intelligence (AI) platform: AI-Immunology™. The AI-Immunology™ platform consists of five proprietary and scalable AI prediction models harnessing the power of data, machine learning and artificial intelligence to decode the human immune system. This enables the development of novel vaccines for the treatment of cancer as well as bacterial and viral infections.
In the news
Evaxion applies its AI-Immunology™ platform in autoimmune diseases ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
cash flow · annual statements
| Line item | Q4 2021 | Q3 2021 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Profit or LossUSD | — | -5,250,000Source | -4,831,000Source | -6,198,000Source | -5,683,000Source | -4,768,000Source | -6,819,000Source | -5,791,000Source | -7,707,000Source | -10,567,000Source | -22,125,000Source | -23,169,000Source |
| Additional Financial Items | ||||||||||||
| AdjustmentsForFinanceIncomeUSD | — | — | — | — | — | — | — | — | 4,616,000Source | — | — | — |
| AdjustmentsForIncomeTaxExpenseUSD | — | — | — | — | — | — | — | — | -908,000Source | — | -790,000Source | -772,000Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | — | — | — | — | — | — | — | — | — | 449,000Source | -502,000Source | 599,000Source |
| AdjustmentsForSharebasedPaymentsUSD | — | — | — | — | — | — | — | — | 307,000Source | 357,000Source | 479,000Source | 942,000Source |
| GeneralAndAdministrativeExpenseUSD | — | 1,495,000Source | 2,212,000Source | 1,983,000Source | 2,741,000Source | 2,147,000Source | 1,915,000Source | 1,595,000Source | 6,787,000Source | 7,619,000Source | 10,354,000Source | 8,208,000Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD | — | — | — | — | — | — | — | — | -1,632,000Source | 0Source | 1,597,000Source | 754,000Source |
| IncreaseDecreaseInWorkingCapitalUSD | — | — | — | — | — | — | — | -2,169,000Source | — | -520,000Source | 1,562,000Source | -2,877,000Source |
| InterestPaidClassifiedAsOperatingActivitiesUSD | — | — | — | — | — | — | — | 97,000Source | 107,000Source | 56,000Source | 65,000Source | 172,000Source |
| InterestReceivedClassifiedAsOperatingActivitiesUSD | — | — | — | — | — | — | — | — | 299,000Source | 254,000Source | 154,000Source | 13,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | — | 81,000Source | 352,000Source | 331,000Source | 326,000Source | 305,000Source |
| ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | — | 7,849,000Source | 0Source | 0Source | 65,000Source | 7,849,000Source |
| ProceedsFromIssuingSharesUSD | — | — | — | — | — | — | — | — | 23,161,000Source | 16,550,000Source | 9,168,000Source | 428,000Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | — | — | — | — | — | — | — | — | — | 0Source | — | — |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | — | 30,000Source | 399,000Source | 805,000Source | 371,000Source | 119,000Source |
income statement · annual statements
| Line item | Q4 2021 | Q3 2021 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 37,000Source | 154,000Source | 0Source | — | — | — | 7,528,000Source | 3,344,000Source | 73,000Source | — |
| Additional Financial Items | ||||||||||||
| ApplicableTaxRatenumber | — | — | — | — | — | — | — | — | 0.22Source | 0.22Source | 0.22Source | 0.22Source |
| AverageEffectiveTaxRatenumber | — | — | — | — | — | — | — | — | 0.1Source | 0.07Source | 0.04Source | 0.04Source |
| BasicEarningsLossPerShareUSD per share | — | — | -0.02Source | -0.12Source | -0.21Source | -0.2Source | -0.36Source | -0.25Source | -0.02Source | -0.2Source | -0.81Source | -0.98Source |
| CurrentTaxExpenseIncomeUSD | — | — | — | — | — | — | — | — | -908,000Source | -788,000Source | — | — |
| DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssetsUSD | — | — | — | — | — | — | — | — | 615,000Source | 608,000Source | — | — |
| DepreciationRightofuseAssetsUSD | — | — | — | — | — | — | — | — | 254,000Source | 203,000Source | 216,000Source | 214,000Source |
| DilutedEarningsLossPerShareUSD per share | — | — | — | — | -0.21Source | -0.2Source | -0.36Source | -0.25Source | — | — | -0.81Source | -0.98Source |
| EmployeeBenefitsExpenseUSD | — | — | — | — | — | — | — | — | 8,539,000Source | 7,341,000Source | — | — |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | — | — | — | — | — | 300,000Source | 400,000Source | — | 307,000Source | 177,000Source | 479,000Source | 942,000Source |
| FinanceCostsUSD | — | 51,000Source | 1,232,000Source | 2,036,000Source | 278,000Source | 225,000Source | 495,000Source | 158,000Source | 3,997,000Source | 3,123,000Source | 1,681,000Source | 1,508,000Source |
| FinanceIncomeUSD | — | 288,000Source | 546,000Source | 220,000Source | 47,000Source | 1,539,000Source | 33,000Source | 519,000Source | 4,616,000Source | 6,500,000Source | 963,000Source | 2,831,000Source |
| GeneralAndAdministrativeExpenseUSD | — | 1,495,000Source | 2,212,000Source | 1,983,000Source | 2,741,000Source | 2,147,000Source | 1,915,000Source | 1,595,000Source | 6,787,000Source | 7,619,000Source | 10,354,000Source | 8,208,000Source |
| ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillUSD | — | — | — | — | — | — | — | — | — | — | — | 87,000Source |
| IncomeTaxExpenseContinuingOperationsUSD | — | -425,000Source | -195,000Source | -199,000Source | -225,000Source | -177,000Source | -669,000Source | -247,000Source | -908,000Source | -788,000Source | -790,000Source | -772,000Source |
| InterestExpenseUSD | — | — | 202,000Source | 185,000Source | 177,000Source | — | — | — | 0Source | 0Source | 1,000Source | 34,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | — | — | 39,000Source | 40,000Source | 44,000Source | — | — | — | 152,000Source | 161,000Source | 172,000Source | 176,000Source |
| NetForeignExchangeLossUSD | — | — | 337,000Source | 123,000Source | 0Source | — | — | — | 738,000Source | 383,000Source | 430,000Source | 710,000Source |
| OtherEmployeeExpenseUSD | — | — | — | — | — | — | — | — | 230,000Source | 97,000Source | 216,000Source | 389,000Source |
| ProfitLossAttributableToOwnersOfParentUSD | — | -5,250,000Source | -4,831,000Source | -6,198,000Source | -5,683,000Source | -4,768,000Source | -6,819,000Source | -5,791,000Source | -7,707,000Source | -10,567,000Source | -22,125,000Source | -23,169,000Source |
| ProfitLossBeforeTaxUSD | — | -5,675,000Source | -5,026,000Source | -6,397,000Source | -5,908,000Source | -4,945,000Source | -7,488,000Source | -6,038,000Source | -8,615,000Source | -11,355,000Source | -22,915,000Source | -23,941,000Source |
| ProfitLossFromOperatingActivitiesUSD | — | -5,912,000Source | -4,340,000Source | -4,581,000Source | -5,677,000Source | -6,259,000Source | -7,026,000Source | -6,399,000Source | -9,234,000Source | -14,732,000Source | -22,197,000Source | -25,264,000Source |
| ResearchAndDevelopmentExpenseUSD | — | 4,417,000Source | 2,165,000Source | 2,752,000Source | 2,936,000Source | 4,112,000Source | 5,111,000Source | 4,804,000Source | 9,975,000Source | 10,457,000Source | 11,916,000Source | 17,056,000Source |